the safety of Arava (leflunomide)
May 2002
There's growing concern over the safety of Arava (leflunomide).
An influential consumer group is asking the FDA to take Arava off the market in the U.S. In the last 5 years they've petitioned to ban Redux...Rezulin...Trovan...Lotronex...and Meridia.
Now they're going after Arava.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive